Quanterix Corporation (QTRX)

NASDAQ: QTRX · IEX Real-Time Price · USD
13.38
-0.08 (-0.59%)
Dec 2, 2022 4:00 PM EST - Market closed
-0.59%
Market Cap 498.76M
Revenue (ttm) 109.99M
Net Income (ttm) -98.15M
Shares Out 37.00M
EPS (ttm) -1.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 110,686
Open 13.09
Previous Close 13.46
Day's Range 12.67 - 13.39
52-Week Range 6.31 - 44.86
Beta 1.31
Analysts Sell
Price Target 13.26 (-0.9%)
Earnings Date Nov 8, 2022

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrume... [Read more]

Industry Life Sciences Tools & Services
IPO Date Dec 7, 2017
Employees 460
Stock Exchange NASDAQ
Ticker Symbol QTRX
Full Company Profile

Financial Performance

In 2021, Quanterix's revenue was $110.56 million, an increase of 27.99% compared to the previous year's $86.38 million. Losses were -$57.69 million, 83.0% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for QTRX stock is "Sell." The 12-month stock price forecast is 13.26, which is a decrease of -0.90% from the latest price.

Price Target
$13.26
(-0.90% downside)
Analyst Consensus: Sell
Stock Forecasts

News

Quanterix to Participate in the 15th Clinical Trials on Alzheimer's Disease (CTAD) Task Force

BILLERICA, Mass.--( BUSINESS WIRE )--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced plans to participate in the ...

2 weeks ago - Business Wire

Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

BILLERICA, Mass.--( BUSINESS WIRE )--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Exe...

3 weeks ago - Business Wire

Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 4.76% and 18.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Quanterix' Third Quarter 2022 Earnings Conference Call

BILLERICA, Mass.

1 month ago - Business Wire

Wall Street Analysts Predict a 73% Upside in Quanterix Corporation (QTRX): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 73.2% in Quanterix Corporation (QTRX). While the effectiveness of this highly sought-after metric is questionable...

2 months ago - Zacks Investment Research

Quanterix Corp - Insiders Are Buying Near All-Time Lows

After reaching dizzying heights during the beginning of the Covid pandemic (which is still on-going if anyone noticed!), Quanterix Corp. ( QTRX , Financial) has now dropped to all-time lows.

3 months ago - GuruFocus

Quanterix Corporation (QTRX) Loses 53.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Quanterix Corporation (QTRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...

3 months ago - Zacks Investment Research

Why Quanterix Stock Bounced Back on Wednesday

The market might, just might, have over-reacted to the company's dispiriting second-quarter results the previous day.

3 months ago - The Motley Fool

Why Quanterix Shares Plunged by Nearly 55% Today

Investors gave the thumbs-down to the biotech's latest reported quarter.

3 months ago - The Motley Fool

Quanterix Corporation (QTRX) Reports Q2 Loss, Lags Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 0% and 20.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced that E. Kevin Hrusovsky is...

3 months ago - Business Wire

Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Re...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced operating results for the ...

3 months ago - Business Wire

Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced that President and Chief E...

4 months ago - Business Wire

Strength Seen in Quanterix Corporation (QTRX): Can Its 5.1% Jump Turn into More Strength?

Quanterix Corporation (QTRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength ...

4 months ago - Zacks Investment Research

Quanterix' Second Quarter 2022 Earnings Conference Call

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced it will host a conference ...

4 months ago - Business Wire

Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications ...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced the validation of a labora...

4 months ago - Business Wire

Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer

NATICK, Mass.--(BUSINESS WIRE)--Mercy BioAnalytics appoints Dawn Mattoon, PhD, as Chief Operating Officer to strengthen management team behind novel early cancer detection platform.

Other symbols: TMO
4 months ago - Business Wire

Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chie...

5 months ago - Business Wire

Quanterix Announces Appointment of Karen A. Flynn to Board of Directors

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Karen A....

Other symbols: CTLT
5 months ago - Business Wire

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 26.87% and 3.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Quanterix Corporation Releases Operating Results for First Quarter 2022

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation Releases Operating Results for First Quarter 2022

6 months ago - Business Wire

Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022

7 months ago - Business Wire

Quanterix Corporation (QTRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Quanterix Corporation (QTRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Quanterix' Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofil...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced its Simoa® te...

7 months ago - Business Wire